Skip to main content

Navigation group

Type at least 3 characters
1,157 articles

Articles

Original Research

Published on 23 May 2024

Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

  • Patrick-Pascal Strunz
  • Matthias Englbrecht
  • Linus Maximilian Risser
  • Torsten Witte
  • Matthias Froehlich
  • Marc Schmalzing
  • Michael Gernert
  • Astrid Schmieder
  • Peter Bartz-Bazzanella
  • Cay von der Decken
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395968
  • 1,925 views
  • 2 citations

Original Research

Published on 23 May 2024

Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

  • Liisi Raam
  • Ilona Hartmane
  • Skaidra ValiukeviÄŤienÄ—
  • Arfenya E. Karamova
  • Eniko Telegdy
  • Ivan Botev
  • Diana Marina
  • Simone Rubant
  • Teotonio Albuquerque
  • Maria Magdalena Constantin
Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries
Frontiers in Immunology
doi 10.3389/fimmu.2024.1410540
  • 1,418 views